Efficacy and safety of pemetrexed maintenance chemotherapy for advanced non-small cell lung cancer in a real-world setting

類似資料

• 放Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verification
  著者:: Jia, Bo, 等
  出版事項: (2021)
• A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database
  著者:: Jia, Bo, 等
  出版事項: (2020)
• Evaluation of different treatment strategies between right-sided and left-sided pneumonectomy for stage I–IIIA non-small cell lung cancer patients
  著者:: Jia, Bo, 等
  出版事項: (2021)
• Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis
  著者:: Jianjie Li, 等
  出版事項: (2020-08-01)
• Nomogram to predict cause‐specific mortality in extensive‐stage small cell lung cancer: A competing risk analysis
  著者:: Jia Zhong, 等
  出版事項: (2019-09-01)